779 top medical experts on Thrombotic Microangiopathies across 29 countries and 35 U.S. states, including 725 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Thrombotic Microangiopathies: Diseases that result in thrombosis in microvasculature. The two most prominent diseases are purpura, thrombotic thrombocytopenic; and hemolytic-uremic syndrome. Multiple etiological factors include vascular endothelial cell damage due to shiga toxin; factor H deficiency; and aberrant VON willebrand factor formation.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Thrombocytopenia (3,871) and Narrower Categories: Hemolytic-Uremic Syndrome (1,358), Thrombocytopenic Purpura (453).
  4. Clinical Trials ClinicalTrials.gov : at least 26 including 2 Active, 5 Completed, 9 Recruiting


  

        

                    


    Computing Expert Listing ...

);